← Return to Aromatase Inhibitors: Did you decide to go on them or not?

Discussion

Aromatase Inhibitors: Did you decide to go on them or not?

Breast Cancer | Last Active: May 12, 2023 | Replies (1190)
Comment receiving replies
@windyshores

So your Oncotype score helped you decide against radiation. I think that is all that breastcancer.org is saying.

Jump to this post

Replies to "So your Oncotype score helped you decide against radiation. I think that is all that breastcancer.org..."
callalloo | @callalloo | Apr 16, 2022

I'm just taking breastcancer.org's statement as written and pointing out that it is incorrect.

The OncotypeDX does not, in fact,
"predict(s) the likelihood of benefit from...radiation' therapy treatment" as stated in the excerpt you cited below. It does not make any radiation predictions at all.

"So, the Oncotype DX Breast Recurrence Score Test is both a prognostic test, since it provides more information about how likely (or unlikely) the breast cancer is to come back, and a predictive test, since it predicts the likelihood of benefit from chemotherapy or radiation therapy treatment. Studies have shown that Oncotype DX Breast Recurrence Score Test is useful for both purposes."

VIEW AND REPLY